Avectas Information
Summary
Avectas is a private company that has been in the industry for 14 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the Co-Founder & CEO is occupied by Michael Maguire. Its headquarters is located at Cambridge, Massachusetts, USA. The number of employees ranges from 25 to 100. The annual revenue of Avectas varies between 100K and 5.0M. Total funding of the company - $32.6M. To connect with Avectas employee register on SignalHire.
Organization Website | avectas.com |
Social Links |   |
Industries | |
Headquarters Location | Ground Floor Building 10,, Dublin, D18 T3Y1 IE |
Employees Size | 10-50 employees |
Specialties | Cell Engineering, Transfection, Cell Therapy, CAR-T, Gene Editing, Gene Therapy, CRISPR |
SIC Code | 2834 |
DMA Code | Greater Boston |
Founded | 2011 |
Estimated Annual Revenue | $100K - 5.0M |
Operating Status | Independent Company |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2014 | Privately Held | 1 - 25 | < 1M | $68.4M | |
| 2009 | Public Company | 1.0K - 5.0K | 45M | $634.9M | |
| 1993 | Public Company | 200-500 | - | $- | |
| 1995 | - | 200-500 | - | $- |
Employees Turnover 4 quarter 2025
Number of employees switched from or switched to
Length of Employment
Employee tenure at Avectas shows a diverse range of experience levels:
5% have been with the company for less than 1 year14% for 1–2 years10% for 3–4 years24% for 5–7 years24% for 8–10 years24% have over 11 years of service at AvectasEx-employees positions
Similar Companies
FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
